Journal article

Intensive management of obesity in people with severe chronic kidney disease: A review

Richard Song, Brendan J Nolan, Hecham Harb, Priya Sumithran

DIABETES OBESITY & METABOLISM | WILEY | Published : 2021

Abstract

Obesity is highly prevalent worldwide, including among people with chronic kidney disease (CKD). The presence of severe and/or end-stage kidney disease complicates the treatment of obesity for several reasons, including restrictions on protein and fluid intake and renal excretion of several medications indicated for the treatment of obesity. The aim of this review is to assess the safety of intensive obesity treatments, such as very-low-energy diets (VLEDs), obesity pharmacotherapy and/or bariatric surgery, in people with end-stage kidney disease. A literature search was conducted to identify studies reporting safety outcomes for VLEDs, liraglutide, phentermine, phentermine-topiramate, naltr..

View full abstract